Prostate Cancer Drugs Market, By Drug Class (Hormonal Therapy, Chemotherapy, Immunotherapy and Targeted Therapy), By Stage of Treatment, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Prostate Cancer Drugs Market size was valued at USD 17,497.21 Million in 2023, expanding at a CAGR of 6.98% from 2024 to 2032.
The Prostate Cancer Drugs Market encompasses pharmaceuticals specifically designed to treat prostate cancer, a prevalent malignancy among men worldwide. The increasing incidence of prostate cancer, coupled with advancements in treatment modalities, is propelling market growth. According to the World Health Organization, prostate cancer is among the top three most diagnosed cancers globally, with over 1.4 million new cases reported in 2020. Moreover, the rising awareness about early diagnosis and the availability of innovative treatment options, such as targeted therapies and immunotherapies, are contributing to market expansion. However, high costs associated with new therapies and stringent regulatory frameworks can hinder market progress. There are significant opportunities in emerging markets, where rising healthcare expenditure and growing populations are expected to increase the demand for prostate cancer drugs. Additionally, the development of personalized medicine and combination therapies offers a promising avenue for enhancing treatment efficacy and improving patient outcomes in this evolving market.
Prostate Cancer Drugs Market- Market Dynamics
Rising Awareness of Early Diagnosis Drives Growth in the Prostate Cancer Drugs Market
Rising awareness of early diagnosis significantly contributes to the growth of the prostate cancer drugs market, as more individuals undergo screening and seek treatment options. According to the American Cancer Society, about 1 in 8 men will be diagnosed with prostate cancer during their lifetime, underscoring the need for effective therapies. Initiatives such as the “Know Your Stats” campaign by the Prostate Cancer Foundation aim to educate men about the importance of early detection, leading to timely treatment and better outcomes. Furthermore, advancements in diagnostic technologies, such as MRI and prostate-specific antigen (PSA) testing, have improved early detection rates, enhancing treatment efficacy. As healthcare providers increasingly emphasize preventive measures, the demand for innovative prostate cancer medications continues to rise, presenting opportunities for pharmaceutical companies to expand their portfolios in this vital therapeutic area.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PROSTATE CANCER DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
AbbVie Inc.
Amgen Inc.
Astellas Pharma Inc.
AstraZeneca PLC
Bayer AG
Bristol-Myers Squibb Company
Clovis Oncology, Inc.
Eli Lilly and Company
Endo Pharmaceuticals Inc.
Johnson & Johnson
Merck & Co., Inc.
Myovant Sciences Ltd.
Novartis AG
Pfizer Inc.
Roche Holding AG
Sanofi S.A.
Others
GLOBAL PROSTATE CANCER DRUGS MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019 - 2032
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
GLOBAL PROSTATE CANCER DRUGS MARKET, BY STAGE OF TREATMENT- MARKET ANALYSIS, 2019 - 2032
Localized Prostate Cancer
Metastatic Prostate Cancer
Castration-Resistant Prostate Cancer (CRPC)
GLOBAL PROSTATE CANCER DRUGS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032
Oral
Injectable
GLOBAL PROSTATE CANCER DRUGS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
Hospitals
Cancer Clinics
Ambulatory Surgical Centers
GLOBAL PROSTATE CANCER DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Prostate Cancer Drugs Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Prostate Cancer Drugs Market Snippet by Drug Class
2.1.2. Prostate Cancer Drugs Market Snippet by Stage of Treatment
2.1.3. Prostate Cancer Drugs Market Snippet by Route of Administration
2.1.4. Prostate Cancer Drugs Market Snippet by End-User
2.1.5. Prostate Cancer Drugs Market Snippet by Country
2.1.6. Prostate Cancer Drugs Market Snippet by Region
2.2. Competitive Insights
3. Prostate Cancer Drugs Key Market Trends
3.1. Prostate Cancer Drugs Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Prostate Cancer Drugs Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Prostate Cancer Drugs Market Opportunities
3.4. Prostate Cancer Drugs Market Future Trends
4. Prostate Cancer Drugs Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Prostate Cancer Drugs Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Prostate Cancer Drugs Market Landscape
6.1. Prostate Cancer Drugs Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Prostate Cancer Drugs Market – By Drug Class
7.1. Overview
7.1.1. Segment Share Analysis, By Drug Class, 2023 & 2032 (%)
7.1.2. Hormonal Therapy
7.1.3. Chemotherapy
7.1.4. Immunotherapy
7.1.5. Targeted Therapy
8. Prostate Cancer Drugs Market – By Stage of Treatment
8.1. Overview
8.1.1. Segment Share Analysis, By Stage of Treatment, 2023 & 2032 (%)
8.1.2. Localized Prostate Cancer
8.1.3. Metastatic Prostate Cancer
8.1.4. Castration-Resistant Prostate Cancer (CRPC)
9. Prostate Cancer Drugs Market – By Route of Administration
9.1. Overview
9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
9.1.2. Oral
9.1.3. Injectable
10. Prostate Cancer Drugs Market – By End-User
10.1. Overview
10.1.1. Segment Share Analysis, By Stage of Treatment, 2023 & 2032 (%)
10.1.2. Hospitals
10.1.3. Cancer Clinics
10.1.4. Ambulatory Surgical Centers
11. Prostate Cancer Drugs Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Prostate Cancer Drugs Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Prostate Cancer Drugs Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Prostate Cancer Drugs Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Prostate Cancer Drugs Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Prostate Cancer Drugs Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Stage of Treatment, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Prostate Cancer Drugs Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. AbbVie Inc.
12.2.2. Amgen Inc.
12.2.3. Astellas Pharma Inc.
12.2.4. AstraZeneca PLC
12.2.5. Bayer AG
12.2.6. Bristol-Myers Squibb Company
12.2.7. Clovis Oncology, Inc.
12.2.8. Eli Lilly and Company
12.2.9. Endo Pharmaceuticals Inc.
12.2.10. Johnson & Johnson
12.2.11. Merck & Co., Inc.
12.2.12. Myovant Sciences Ltd.
12.2.13. Novartis AG
12.2.14. Pfizer Inc.
12.2.15. Roche Holding AG
12.2.16. Sanofi S.A.
12.2.17. Others
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
